API
< Back to all clusters
[BUSINESS] · Germany, France, Switzerland · 2 sources

started · updated

Barclays adjusts ratings for Deutsche Börse and DocMorris

Barclays has implemented a revaluation of the European exchange sector, leading to changes in its outlook for Deutsche Börse and DocMorris.

Analyst Grace Dargan downgraded Deutsche Börse from “Overweight” to “Equal Weight,” maintaining a price target of 320 euros. Dargan shifted focus toward Euronext, assigning it an “Overweight” rating with a price target of 210 euros, citing its dynamic earnings growth and attractive valuation.

Regarding DocMorris, analyst Andrew Ross raised the twelve-month price target from 12 CHF to 19 CHF while maintaining an “Equal Weight” rating. The adjustment follows quarterly reports and a capital markets day. While DocMorris reported a slight positive adjusted EBITDA in the third quarter of 2026 and saw a 90 percent increase in German prescription revenue in October 2026, Barclays remains neutral, focusing on the company's ability to convert growth into sustained profitability.

Entities

Barclays · Deutsche Börse · DocMorris · Euronext · Grace Dargan